Eiger Biopharmaceutica Correlations
| EIGRDelisted Stock | USD 0.74 0.03 3.90% |
The current 90-days correlation between Eiger Biopharmaceuticals and Bolt Biotherapeutics is 0.12 (i.e., Average diversification). The correlation of Eiger Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Eiger Biopharmaceutica Correlation With Market
Significant diversification
The correlation between Eiger Biopharmaceuticals and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eiger Biopharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Eiger |
Moving together with Eiger Stock
| 0.7 | SHG | Shinhan Financial | PairCorr |
| 0.73 | EC | Ecopetrol SA ADR | PairCorr |
| 0.8 | HYMTF | Hyundai Motor | PairCorr |
| 0.84 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.85 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.65 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.63 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Eiger Stock
| 0.8 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.77 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.76 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.7 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.68 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.65 | KB | KB Financial Group | PairCorr |
| 0.65 | WMT | Walmart Aggressive Push | PairCorr |
| 0.63 | HPQ | HP Inc | PairCorr |
| 0.62 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.62 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.44 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.41 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.33 | KEP | Korea Electric Power | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eiger Stock performing well and Eiger Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eiger Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SPRO | 1.78 | (0.27) | 0.00 | (0.41) | 0.00 | 3.79 | 14.92 | |||
| BOLT | 1.69 | (0.25) | 0.00 | (2.95) | 0.00 | 4.76 | 14.96 | |||
| CHRS | 4.02 | (0.19) | 0.00 | (0.16) | 0.00 | 7.62 | 34.15 | |||
| GRCL | 5.71 | 1.25 | 0.18 | 1.02 | 6.35 | 16.34 | 52.11 | |||
| NLTX | 2.25 | (0.22) | 0.00 | (0.55) | 0.00 | 4.05 | 27.84 | |||
| CING | 5.31 | (1.10) | 0.00 | (1.72) | 0.00 | 9.27 | 38.00 | |||
| LYRA | 4.16 | (0.70) | 0.00 | (0.40) | 0.00 | 8.00 | 41.07 | |||
| FNCH | 4.29 | (0.15) | 0.00 | 0.41 | 0.00 | 6.33 | 64.67 | |||
| APLT | 3.83 | 1.09 | 0.23 | 4.19 | 3.45 | 5.60 | 78.72 | |||
| XFOR | 4.97 | (0.84) | 0.00 | (0.45) | 0.00 | 6.90 | 62.35 |
View Eiger Biopharmaceutica Related Equities
| Risk & Return | Correlation |
Eiger Biopharmaceutica Corporate Management
| Sriram MBA | Chief Officer | Profile | |
| James JD | Chief Counsel | Profile | |
| Christopher Kurtz | Chief Officer | Profile | |
| Ingrid Choong | VP Devel | Profile | |
| Colleen MD | Senior Diseases | Profile | |
| Erik Atkisson | Corp Counsel | Profile |
Still Interested in Eiger Biopharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.